Arovella Therapeutics Ltd
ASX:ALA
Arovella Therapeutics Ltd
ASX:ALA
Price:
0.09
AUD
-3.23%
Market Closed
Market Cap:
AU$108.1m
Cash Flow Statement
Cash Flow Statement
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Currency: AUD
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Cash from Operating Activities |
(3)
N/A
|
(4)
-6%
|
(4)
-11%
|
(6)
-59%
|
(7)
-6%
|
(6)
+4%
|
(6)
0%
|
(7)
-8%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-417%
|
(0)
+41%
|
(1)
-86%
|
(1)
+6%
|
0
N/A
|
0
-89%
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
7
|
10
|
3
|
6
|
6
|
5
|
8
|
15
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Cash from Financing Activities |
7
N/A
|
10
+49%
|
3
-68%
|
6
+97%
|
6
+2%
|
5
-14%
|
8
+41%
|
15
+92%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
3
N/A
|
6
+86%
|
(1)
N/A
|
(1)
+41%
|
(1)
-35%
|
(1)
-2%
|
1
N/A
|
8
+502%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(3)
N/A
|
(4)
-17%
|
(4)
-4%
|
(7)
-61%
|
(7)
-5%
|
(6)
+11%
|
(6)
-1%
|
(7)
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
